Clinical Trials Browser

Phase 2 × futuximab × Gastrointestinal × Clear all

NCT03549338 2020-09-28

Sym004 Versus Futuximab or Modotuximab in Patients With mCRC

Phase 2 Terminated

2 enrolled 9 charts

Gastrointestinal

Carcinoma, Colorectal Neoplasms

NCT02083653 2019-04-16

Sym004 vs Standard of Care in Subjects With Metastatic Colorectal Cancer

Phase 2 Completed

254 enrolled 21 charts

Gastrointestinal

Colorectal Neoplasms

NCT02965417 2017-02-01

Sym004 in Metastatic Colorectal Cancer and ECD-EGFR Patients

Phase 2 Withdrawn

Gastrointestinal

Colorectal Neoplasms